Huntington's disease
| 7 min read
A one-time gene therapy aims to stop Huntington's disease at its source. But first, it has to survive clinical trials.
Page 1 of 1 - 1 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Getting to the heart of drug safety testing
High throughput optical scanning enhances cardiac ion channel analysis for safer drug development.
Harnessing CRISPR-Cas9: Knocking out genes in myeloid cells
Explore the applications of CRISPR-Cas9 technology in therapeutic development for Alzheimer’s disease.
Harnessing liver-on-a-chip models for drug safety
Discover how researchers leverage microphysiological systems in toxicology studies.
